AFAP1 and lung carcinoma: He et al. found that lncRNA AFAP1-AS1 expression correlated negatively with the promoter CpG methylation status in both lung cancer cells and patient tissues, and the DNA methyltransferase inhibitor decitabine significantly increased AFAP1-AS1 expression [24].